News und Analysen
Viatris Aktie: Kommt die Trendwende?
Nach einer langen Talfahrt zeigt die Viatris-Aktie endlich wieder Lebenszeichen. Der Grund: Der Pharmakonzern…
Der Beitrag Viatris Aktie: Kommt die Trendwende? erschien zuerst auf kapitalmarktexpert
DaVita Stock: Berkshire Sale Triggers 4% Price Drop
DaVita's stock has experienced a significant downturn, with shares falling 4% to $148.49, representing a decline of $6.47 per share. This market movement comes in direct response to Berkshire
Viatris Misses Estimates, Cash Flow Up
Viatris (NASDAQ:VTRS), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Viatris, Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS) and reminds investors of the June
